Granulocyte-macrophage colony-stimulating factor as a mediator of autoimmunity in multiple sclerosis

This publication has 137 references indexed in Scilit:

• The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)
  Seminars in Immunology, 2003
• Priming effects of GM-CSF, IFN-γ and TNF-α on human neutrophil inflammatory cytokine production
  Melanoma Research, 2002
• Granulocyte Macrophage Colony-Stimulating Factor
  Journal of Experimental Medicine, 2001
• Release of GM‐CSF and G‐CSF by human arterial and venous smooth muscle cells: differential regulation by COX‐2
  British Journal of Pharmacology, 2000
• Serum levels of GM‐CSF are elevated in patients with thrombocytopenia
  British Journal of Haematology, 1996
• GM‐CSF promotes proliferation of human fetal and adult microglia in primary cultures
  Glia, 1994
• Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.
  Proceedings of the National Academy of Sciences, 1994
• Markers of Activated T Lymphocytes and T Cell Receptor Gamma/ Delta+ in Patients with Multiple Sclerosis
  European Neurology, 1993
• The T Lymphocyte in Experimental Allergic Encephalomyelitis
  Annual Review of Immunology, 1990
• Recombinant human granulocytemacrophage colony-stimulating factor induces granule exocytosis from human polymorphonuclear neutrophils
  Inflammation, 1990